Cambridge, Massachusetts-based Immunitas Therapeutics, a single cell genomics-based drug discovery company founded by Longwood Fund, has secured $39 million in Series A financing. Leaps by Bayer and Novartis Venture Fund led the round.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.